217 related articles for article (PubMed ID: 25577826)
1. Percutaneous left atrial appendage closure therapy for the prevention of stroke.
Blue Cross Blue Shield Asssociation
Technol Eval Cent Assess Program Exec Summ; 2014 Oct; 29(5):1-4. PubMed ID: 25577826
[No Abstract] [Full Text] [Related]
2. Medical device regulatory reform: insights from the watchman left atrial appendage closure technology for stroke prophylaxis in atrial fibrillation.
Cingolani E; Stevens S; Shehata M; Diamond GA; Kaul S
Arch Intern Med; 2011 Oct; 171(18):1670-2. PubMed ID: 21746999
[No Abstract] [Full Text] [Related]
3. Percutaneous mitral valve repair.
Blue Cross Blue Shield Asssociation
Technol Eval Cent Assess Program Exec Summ; 2014 Oct; 29(4):1-3. PubMed ID: 25577825
[No Abstract] [Full Text] [Related]
4. Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges.
Syed TM; Halperin JL
Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):428-35. PubMed ID: 17653115
[TBL] [Abstract][Full Text] [Related]
5. Left atrial appendage closure: An emerging option in atrial fibrillation when oral anticoagulants are not tolerated.
Peritz DC; Chung EH
Cleve Clin J Med; 2015 Mar; 82(3):167-76. PubMed ID: 25932742
[TBL] [Abstract][Full Text] [Related]
6. Closure of Left Atrial Appendage to Prevent Stroke: Devices and Status.
Safavi-Naeini P; Rasekh A
Tex Heart Inst J; 2018 Jun; 45(3):172-174. PubMed ID: 30072856
[No Abstract] [Full Text] [Related]
7. Nonpharmacologic stroke prevention in atrial fibrillation.
Onalan O; Lashevsky I; Hamad A; Crystal E
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):619-33. PubMed ID: 16076273
[TBL] [Abstract][Full Text] [Related]
8. Overview of the Food and Drug Administration circulatory system devices panel meetings on WATCHMAN left atrial appendage closure therapy.
Waksman R; Pendyala LK
Am J Cardiol; 2015 Feb; 115(3):378-84. PubMed ID: 25579887
[TBL] [Abstract][Full Text] [Related]
9. Left Atrial Appendage Closure for Stroke Prevention: Devices, Techniques, and Efficacy.
Iskandar S; Vacek J; Lavu M; Lakkireddy D
Cardiol Clin; 2016 May; 34(2):329-51. PubMed ID: 27150181
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience.
Faustino A; Paiva L; Providência R; Trigo J; Botelho A; Costa M; Leitão-Marques A
Rev Port Cardiol; 2013 Jun; 32(6):461-71. PubMed ID: 23639325
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous left atrial appendage closure is not ready for routine clinical use.
Mandrola J; Foy A; Naccarelli G
Heart Rhythm; 2018 Feb; 15(2):298-301. PubMed ID: 29030233
[No Abstract] [Full Text] [Related]
12. Percutaneous left atrial appendage closure for stroke prevention in India: The beginning of a new era.
Aminian A; Khalil G; Tzikas A
Indian Heart J; 2015 Dec; 67 Suppl 2(Suppl 2):S4-6. PubMed ID: 26688151
[No Abstract] [Full Text] [Related]
13. Left atrial appendage closure devices: A reasonable therapeutic alternative.
Reddy VY
Heart Rhythm; 2018 Feb; 15(2):302-305. PubMed ID: 29030234
[No Abstract] [Full Text] [Related]
14. Atrial fibrillation and stroke: risk factors, anticoagulation, and left atrial appendage occluders.
Lüscher TF
Eur Heart J; 2016 Aug; 37(31):2443-5. PubMed ID: 27558318
[No Abstract] [Full Text] [Related]
15. Remaining Challenges With Transcatheter Left Atrial Appendage Closure.
Alkhouli M; Holmes DR
Mayo Clin Proc; 2020 Oct; 95(10):2244-2248. PubMed ID: 33012352
[TBL] [Abstract][Full Text] [Related]
16. Where We Stand on Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation.
Safavi-Naeini P; Rasekh A
Tex Heart Inst J; 2016 Aug; 43(4):320-3. PubMed ID: 27547142
[No Abstract] [Full Text] [Related]
17. 2015 ACC/HRS/SCAI left atrial appendage occlusion device societal overview.
Masoudi FA; Calkins H; Kavinsky CJ; Drozda JP; Gainsley P; Slotwiner DJ; Turi ZG
Heart Rhythm; 2015 Oct; 12(10):e122-36. PubMed ID: 26134035
[No Abstract] [Full Text] [Related]
18. Self-expandable device for percutaneous closing of left atrial appendage with organized thrombus in a patient with permanent atrial fibrillation.
Pak HN; Shim CY; Kim JS; Park JW; Jang Y
Can J Cardiol; 2013 Oct; 29(10):1329.e1-1329.e3. PubMed ID: 23228490
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of Left Atrial Appendage Closure Versus Anticoagulation in Patients With Atrial Fibrillation.
Kheiri B; Kumar K; Simpson TF; Osman M; Dalouk K; Beitinjaneh B; Golwala H; Henrikson CA
Am J Cardiol; 2020 Oct; 132():181-182. PubMed ID: 32778338
[No Abstract] [Full Text] [Related]
20. Left Atrial Appendage and Closure: Who, When, and How.
Holmes DR; Reddy VY
Circ Cardiovasc Interv; 2016 May; 9(5):e002942. PubMed ID: 27139910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
